Page last updated: 2024-11-05

thalidomide and Intraocular Pressure

thalidomide has been researched along with Intraocular Pressure in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Intraocular Pressure: The pressure of the fluids in the eye.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with thalidomide also blocked the ocular hypotension induced by latanoprost; however, thalidomide pretreatment enhanced the duration of the initial hypertension."5.35Latanoprost-induced changes in rat intraocular pressure: direct or indirect? ( Crosson, CE; Husain, S; Yates, PW, 2008)
"Pretreatment with thalidomide also blocked the ocular hypotension induced by latanoprost; however, thalidomide pretreatment enhanced the duration of the initial hypertension."1.35Latanoprost-induced changes in rat intraocular pressure: direct or indirect? ( Crosson, CE; Husain, S; Yates, PW, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Husain, S1
Yates, PW1
Crosson, CE1

Other Studies

1 other study available for thalidomide and Intraocular Pressure

ArticleYear
Latanoprost-induced changes in rat intraocular pressure: direct or indirect?
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:4

    Topics: Administration, Topical; Animals; Dipeptides; Intraocular Pressure; Latanoprost; Male; Matrix Metall

2008